profit from every $100 of sales.
$0$100
Retractable Technologies
$0.56+0.88% today
-30.9% in 1 year
1-year low $0.551-year high $0.83
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Retractable Technologies sold, what it kept, and what it did with the cash.
Sales went from $94.8 million in 2022 to $38.3 million in 2025, with -$12.6 million of profit last year.
SalesProfit
Retractable Technologies vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Retractable Technologies | No profit yet | ||
 ResMed | 22.1× · Fair price | ||
 West Pharmaceutical Services | 58.8× · Expensive | ||
 Hologic | 30.0× · Fair price | ||
 Baxter International | No profit yet |
AI analysis
An AI analyst reads Retractable Technologies's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 95 | 44 | 33 | 38 | |
| 28 | 9 | -1 | 0 | |
| 3 | -5 | -15 | -14 | |
| 10 | -1 | 4 | -4 | |
| 5 | -7 | -12 | -13 | |
| 0.15 | -0.24 | -0.40 | -0.43 | |
| 29.8% | 20.9% | -3.1% | 0.1% | |
| 3.1% | -12.1% | -46.0% | -37.3% | |
| 5.4% | -16.1% | -36.0% | -32.8% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 196 | 180 | 161 | 143 |
| Cash | 20 | 13 | 4 | 3 |
| Total debt | 2 | 2 | 1 | 1 |
| Total liabilities | 89 | 80 | 74 | 68 |
| 107 | 99 | 87 | 74 | |
| 33 | 30 | 30 | 30 | |
| 3.9% | -6.9% | -3.0% | -12.8% | |
| 4.8% | -7.1% | -13.6% | -16.9% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 17 | 3 | -12 | -7 | |
| 17 | 1 | 1 | 1 | |
| -0 | 2 | -13 | -8 | |
| Dividends paid | 0 | 0 | 0 | 0 |
| 9 | 1 | 0 | 0 | |
| 10 | 0 | 0 | – |
Valuation
- –
- –
- –
- 0.3×
- 0.4×
- –
- –
- -45.3%
- -75.0%
- 0.0%
Profitability
- 0.1%
- -37.3%
- -32.8%
- -1.0%
- -17.8%
- 4.4%
- -8.5%
- -4.6%
- -17.8%
- 1.8%
Growth
- −26.1%
- –
- +41.5%
- –
- −3.0%
Financial health
- -0.4×
- 0.01
- 0.7%
- -267.0×
- 5.74
- 4.17
- 0.27
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 20%of 952
Bottom 8%of 884
Bottom 4%of 886
Bottom 1%of 987
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 15, 2026 | -0.14 | – | – |
| Mar 27, 2026 | -0.08 | – | – |
| Nov 14, 2025 | 0.01 | – | – |
| Aug 14, 2025 | -0.12 | – | – |
| May 15, 2025 | -0.11 | – | – |
| Mar 28, 2025 | 0.13 | – | – |
| Nov 14, 2024 | -0.07 | – | – |
| Aug 14, 2024 | -0.48 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
33No pass
Benjamin Graham
73Pass
Philip Fisher
34No pass
Peter Lynch
28No pass
Joel Greenblatt
0No pass
Charlie Munger
34No pass
Terry Smith
23No pass
Questions about Retractable Technologies
Is Retractable Technologies a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Retractable Technologies AI analysis
What does Retractable Technologies do?
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It is in Medical - Instruments & Supplies.
Does Retractable Technologies pay a dividend?
Yes. In 2025 it paid out $230,444 in dividends.
Is Retractable Technologies stock halal?
No. Retractable Technologies does not pass our halal screen: its cash and receivables are 64% of its market value, at or above the 49% limit. How we check
How has Retractable Technologies stock done over the past year?
Down 30.9% over the past twelve months, to $0.56. It traded between $0.55 and $0.83 and is 32.9% below its high.
Who are Retractable Technologies's competitors?
The largest listed companies in the same industry are ResMed, West Pharmaceutical Services, Hologic and Baxter International. The peers table on this page compares their profit, growth and price with Retractable Technologies's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.